Business Standard

Saturday, December 21, 2024 | 09:54 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Lessons from Covid: Pharma firms turn attention to adult vaccination

Vaccine companies have warmed up to the idea of adult vaccines for other diseases such as pneumonia, flu and shingles as well

vaccine
Premium

Companies are, in fact, creating new teams as their focus on adult vaccination increases

Sohini Das Mumbai
The Covid-19 pandemic led to the world’s largest adult vaccination campaign, with more than 13 billion doses administered globally, so far. Around 2.5 million doses of Covid-19 vaccines are being administered daily now across the world. Vaccine companies have thus warmed up to the idea of adult vaccination against non-Covid infections, as well  — pneumonia, flu, and shingles, to name a few.
 
According to Pfizer India country president S Sridhar: “While India’s largest vaccination programme for Covid-19 demonstrated utility, acc¬ep¬tance, and system readiness for adult immu¬nisation, a lot more needs to be done. Therefore, Pfizer has been a frontrunner to

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in